logo

For the Inventor, By the Inventor

Tsukuba, Japan

Takahiro Fukuroda

This inventor holds 12 USPTO granted patents. Top assignees: Banyu Pharmaceutical Co. Ltd, Merck + Co., Inc., Other. Active years: 1995-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Fukuroda. Retrieved from https://idiyas.com/inventor/takahiro-fukuroda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 83.3

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 56(Granted Patents)


Location History:

  • Tokyo, JP (1995 - 1996)
  • Tsukuba, JP (2000 - 2001)
  • Ibaraki, JP (2001 - 2003)

Company Filing History:

goldMedal8 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents
silverMedal1 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal3 out of 834,513 
Other
 patents

Years Active: 1995-2003

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6638942 - Spiro-indolines as Y5 receptor antagonists (2003-10-28),
2. 6495559 - NPY Y5 receptor antagonists (2002-12-17),
3. 6313298 - Spiro-indolines as Y5 receptor antagonists (2001-11-06),
4. 6258837 - Neuropeptide Y receptor antagonist (2001-07-10),
5. 6191160 - Spiro-indolines as Y5 receptor antagonists (2001-02-20),
6. 6180653 - Aminopyrazole derivatives (2001-01-30),
7. 6166038 - Aminopyrazole derivatives (2000-12-26),
8. 6057335 - Pyrazole derivatives (2000-05-02),
9. 6043246 - Urea derivatives (2000-03-28),
10. 6011039 - Aminopyridine derivatives (2000-01-04),
11. 5494923 - Method of ameliorating cerebral circulation (1996-02-27),
12. 5444077 - Ameliorant of cerebral circulation and optical isomer of NB-818, (1995-08-22),

Title: The Innovative Mind of Takahiro Fukuroda

Introduction: Takahiro Fukuroda, an accomplished inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals with a total of 12 patents to his name. His work focuses primarily on receptor antagonists, which hold great potential in the development of new therapeutic agents.

Latest Patents: Among his latest patents are groundbreaking innovations such as spiro-indolines as Y5 receptor antagonists and NPY Y5 receptor antagonists. These inventions are pivotal in exploring treatment options for various health conditions, thereby offering hope for improvements in patient care.

Career Highlights: Throughout his career, Takahiro has been associated with Banyu Pharmaceutical Co. Ltd, where he has honed his expertise and driven innovative research in the pharmaceutical industry. His dedication to pushing the boundaries of science is reflected in his extensive patent portfolio.

Collaborations: Takahiro Fukuroda has collaborated effectively with notable peers in the field, including Takehiro Fukami and Akio Kanatani. Their combined efforts have contributed to a wealth of knowledge and innovation within their projects.

Conclusion: As a prominent figure in the field of pharmaceutical inventions, Takahiro Fukuroda continues to inspire future generations of inventors with his groundbreaking work. His numerous patents illustrate a commitment to advancing medical science and improving healthcare solutions for society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…